| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1097/01.TP.0000110408.83054.88 |
| P698 | PubMed publication ID | 15021846 |
| P2093 | author name string | Paul Roderick | |
| Robert C Peveler | |||
| Mark Mullee | |||
| Janet A Butler | |||
| Juan C Mason | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunosuppression | Q1455316 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 769-776 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review | |
| P478 | volume | 77 |
| Q38465779 | A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen |
| Q64081596 | A Nurse-Led Self-Management Support Intervention (ZENN) for Kidney Transplant Recipients Using Intervention Mapping: Protocol for a Mixed-Methods Feasibility Study |
| Q93063618 | A Prospective, Observational Study of Conversion From Immediate- to Prolonged-Release Tacrolimus in Renal Transplant Recipients in France: The OPALE Study |
| Q47770527 | A Study on Adherence to Follow-up, Quality of Life, and Associated Factors Among Renal Transplant Recipients in China |
| Q64227854 | A pragmatic behavior-based habit index for adherence to nebulized treatments among adults with cystic fibrosis |
| Q36941933 | A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients |
| Q47578423 | A significant role for anti-human leukocyte antigen antibodies and antibody-mediated rejection in the biopsy-for-cause population. |
| Q46952602 | A single daily dose enhances the adherence to immunosuppressive treatment in kidney transplant recipients: a cross-sectional study |
| Q40272137 | AAV9-mediated engineering of autotransplanted kidney of non-human primates |
| Q38091722 | Achieving operational tolerance in transplantation: how can lessons from the clinic inform research directions? |
| Q51138763 | Adherence in patients in the first year after kidney transplantation and its impact on graft loss and mortality: a cross-sectional and prospective study. |
| Q38738778 | Adherence in pediatric kidney transplant recipients: solutions for the system |
| Q90704692 | Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden |
| Q102219190 | Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden |
| Q37774840 | Adherence to immunosuppressants: how can it be improved in adolescent organ transplant recipients? |
| Q36613767 | Adherence to immunosuppression: a prospective diary study |
| Q38587538 | Advagraf(®) , a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts |
| Q37800589 | An Approach to the Patient with Organ Failure: Transplantation and End-of-Life Treatment Decisions |
| Q37510999 | An observational study of health literacy and medication adherence in adult kidney transplant recipients |
| Q37811395 | Anxiety, Depression and Emotional Profile in Renal Transplant Recipients and Healthy Subjects: A Comparative Study |
| Q92020856 | Are Generic Immunosuppressive Drugs the Solution for Providing Lifelong Medication Coverage to Transplant Recipients? |
| Q38459121 | Assessing pharmacologic and nonpharmacologic risks in candidates for kidney transplantation |
| Q34183063 | Assessment of transition readiness skills and adherence in pediatric liver transplant recipients |
| Q33516048 | Association between depression and nonadherence in recipients of kidney transplants: analysis of the United States renal data system |
| Q50934660 | Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. |
| Q93063065 | Beliefs of Immunosuppressive Medication Among Chinese Renal Transplant Recipients, as Assessed in a Cross-Sectional Study With the Basel Assessment of Adherence to Immunosuppressive Medications Scale |
| Q37682802 | Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence. |
| Q36884566 | Can mTOR inhibitors reduce the risk of late kidney allograft failure? |
| Q37641415 | Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine |
| Q39009557 | Chronic allograft injury: Mechanisms and potential treatment targets |
| Q90388059 | Clinic Nonattendance Is a Risk Factor for Poor Kidney Transplant Outcomes |
| Q45230211 | Comparing renal transplant patients' adherence to free cyclosporine and free tacrolimus immunosuppressant therapy |
| Q37588122 | Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients |
| Q36740996 | Comparison of the long-term outcomes of kidney transplantation: USA versus Spain. |
| Q92944781 | Conversion From Immediate-Release Tacrolimus to Prolonged-Release Tacrolimus in Stable Heart Transplant Patients: A Retrospective Study |
| Q42611751 | Conversion from Prograf to Advagraf in stable paediatric renal transplant patients and 1-year follow-up |
| Q48191085 | Conversion from twice-daily to once-daily tacrolimus formulation in pediatric liver transplant recipients - a long-term prospective study |
| Q46452808 | Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen |
| Q46453020 | Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen |
| Q43654525 | Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy |
| Q46131428 | Daytime sleepiness in renal transplant recipients is associated with immunosuppressive non-adherence: a cross-sectional, multi-center study. |
| Q34186424 | Depression and anxiety as potential correlates of post-transplantation renal function and quality of life |
| Q51102037 | Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Co |
| Q39296658 | Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients |
| Q34224452 | Diagnosis and prevention of chronic kidney allograft loss |
| Q92824311 | Dietary Patterns of Patients with Chronic Kidney Disease: The Influence of Treatment Modality |
| Q80275374 | Dilemmas in pediatric renal transplantation |
| Q36790345 | Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports |
| Q40746370 | Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction. |
| Q57489275 | Early Outcomes of Living-Donor Kidney Transplantation With Immunosuppression Therapy Induction With Tacrolimus Extended-Release: A Comparison With Cyclosporine |
| Q44376334 | Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol |
| Q64257348 | Effect of an interactive voice response system on self-management in kidney transplant recipients: Protocol for a randomized controlled trial |
| Q91795123 | Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study |
| Q51468070 | Effects of a medication assistance program with medication therapy management on the health of renal transplant recipients. |
| Q87491697 | Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients |
| Q92039749 | Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus - a Phase 2, open-label, single-arm, one-way crossover study |
| Q41871356 | Efficacy of a reduced pill burden on therapeutic adherence to calcineurin inhibitors in renal transplant recipients: an observational study |
| Q39292308 | Efficacy of interventions for adherence to the immunosuppressive therapy in kidney transplant recipients: a meta-analysis and systematic review |
| Q36592209 | Electronically measured adherence to immunosuppressive medications and kidney function after deceased donor kidney transplantation |
| Q36133776 | Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil |
| Q50914001 | Essential components of transition to adult transplant services: the transplant coordinators' perspective. |
| Q33901264 | Evaluation of a telenovela designed to improve knowledge and behavioral intentions among Hispanic patients with end-stage renal disease in Southern California |
| Q83388996 | Evaluation of a transplantation specialty pharmacy program |
| Q47754574 | Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study |
| Q51834008 | Evaluation of non-adherence in patients undergoing dialysis and kidney transplantation: United States transplantation practice patterns survey. |
| Q38263466 | Extended-release tacrolimus: a review of its use in de novo kidney transplantation |
| Q43102995 | Face time: educating face transplant candidates |
| Q36167195 | Factors contributing to acute rejection in renal transplantation: the role of noncompliance |
| Q48955797 | Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients |
| Q59135013 | Health literacy in solid-organ transplantation: a model to improve understanding |
| Q46797786 | Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain |
| Q60306613 | Immunosuppressive therapy related adherence, beliefs and self-management in kidney transplant outpatients |
| Q36595129 | Immunotherapy for De Novo renal transplantation: what's in the pipeline? |
| Q92890923 | Impact of Once- Versus Twice-Daily Tacrolimus Dosing on Medication Adherence in Stable Renal Transplant Recipients: A Canadian Single-Center Randomized Controlled Trial |
| Q91725691 | Impact of Predialysis Psychosocial Conditions on Kidney Transplant Recipient Survival: Evidence Using Propensity Score Matching |
| Q42601974 | Impact of clinical pharmacy services on renal transplant recipients' adherence and outcomes |
| Q36194060 | Impact of simultaneous pancreas-kidney transplantation: patients' perspectives |
| Q50932280 | Impact of stress, distress and feelings of indebtedness on adherence to immunosuppressants following kidney transplantation. |
| Q53674432 | Impact of sympathetic renal denervation: a randomized study in patients after renal transplantation (ISAR-denerve). |
| Q36113092 | Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study |
| Q51519857 | Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation. |
| Q43460637 | Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. |
| Q49645962 | Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients. |
| Q37998967 | Influence of pill burden and drug cost on renal function after transplantation |
| Q91970975 | Information Needs of Patients About Immunosuppressive Medication in a German Kidney Transplant Sample: Prevalence and Correlates |
| Q48603070 | Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study |
| Q94338127 | Interventions for improving medication adherence in solid organ transplant recipients |
| Q47100905 | Interventions to increase adherence in patients taking immunosuppressive drugs after kidney transplantation: a systematic review of controlled trials |
| Q47824289 | Interventions used by health care professionals to enhance medication adherence in transplant patients: a survey of current clinical practice. |
| Q38357915 | Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management |
| Q44630580 | Kidney transplantation complications related to psychiatric or neurological disorders |
| Q52691064 | Leadership Perspectives on Integrating Psychologists into Specialty Care Clinics: An Evolving Paradigm. |
| Q92120465 | Life Quality and Compliance After Transplant: The Case of Turkey |
| Q92413540 | Long-Term Kidney Transplant Outcomes: Role of Prolonged-Release Tacrolimus |
| Q91097552 | Long-term Glomerular Filtration Rate and Kidney Disease: Improving Global Outcomes Stage Stability After Conversion to Once-Daily Tacrolimus in Kidney Transplant Recipients |
| Q64902285 | Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology. |
| Q38078605 | Long-term factors influencing survival after kidney transplantation |
| Q40149564 | Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab. |
| Q84969442 | Long-term interleukin-2 assessment after conversion from a twice-daily to once-daily tacrolimus regimen in stable kidney recipients |
| Q38672740 | Low Adherence to Immunosuppressants Is Associated With Symptom Experience Among Kidney Transplant Recipients |
| Q36078960 | MAGIC Study: Aims, Design and Methods using SystemCHANGE™ to Improve Immunosuppressive Medication Adherence in Adult Kidney Transplant Recipients |
| Q79859105 | Medicare Part D coverage and its influence on transplant patients' out-of-pocket prescription expenses |
| Q37530975 | Medication Nonadherence After Lung Transplantation in Adult Recipients |
| Q49859695 | Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study |
| Q37111816 | Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants |
| Q57147713 | Medication adherence in renal transplant recipients: A latent variable model of psychosocial and neurocognitive predictors |
| Q90353316 | Medication compliance and lifestyle adherence in renal transplant recipients in Kuwait |
| Q90808328 | Medication non-adherence after kidney transplantation: A critical appraisal and systematic review |
| Q36864621 | Medication noncompliance and its implications in transplant recipients |
| Q36861986 | Medication therapy management and adherence among US renal transplant recipients |
| Q38197715 | Medicine non-adherence in kidney transplantation. |
| Q53115798 | Meltdose Tacrolimus Pharmacokinetics. |
| Q51936605 | Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. |
| Q40537018 | Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients |
| Q35855808 | Multilevel Correlates of Non-Adherence in Kidney Transplant Patients Benefitting from Full Cost Coverage for Immunosuppressives: A Cross-Sectional Study. |
| Q40538327 | Nephrologists' management of patient medications in kidney transplantation: results of an online survey |
| Q42376852 | Non-adherence to immunosuppressants following renal transplantation: a protocol for a systematic review |
| Q48263104 | Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the Integrative Model of Behavioral Prediction: a cross-sectional study |
| Q47999916 | Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medication intake |
| Q38736961 | Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? |
| Q38836938 | Nonadherence to therapy after adult solid organ transplantation: A focus on risks and mitigation strategies |
| Q43623678 | Nonmodifiable characteristics associated with nonadherence to immunosuppressant therapy in renal transplant recipients |
| Q37909506 | Nonneoplastic mucocutaneous lesions in organ transplant recipients |
| Q38269284 | Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations |
| Q39153639 | Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients |
| Q26751450 | Overview of extended release tacrolimus in solid organ transplantation |
| Q26829069 | Patient involvement in selection of immunosuppressive regimen following transplantation |
| Q46511526 | Patient outcomes and economics of once-daily tacrolimus in renal transplant patients: results of a modeling analysis |
| Q36473641 | Patient survey to identify reasons for non-adherence and elicitation of quality of life concepts associated with immunosuppressant therapy in kidney transplant recipients |
| Q34024224 | Patient-reported immunosuppression nonadherence 6 to 24 months after liver transplant: association with pretransplant psychosocial factors and perceptions of health status change |
| Q36327259 | Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation |
| Q42849619 | Pharmacokinetics of once- versus twice-daily tacrolimus formulations in kidney transplant patients receiving expanded criteria deceased donor organs: a single-center, randomized study |
| Q38776675 | Pill burden does not influence compliance with oral medication in recipients of renal transplant |
| Q38002977 | Pilot study of a pharmaceutical care intervention in an outpatient lung transplant clinic. |
| Q34266126 | Post-transplant adjustment--the later years |
| Q47633090 | Postoperative cognitive dysfunction and mortality following lung transplantation. |
| Q92991167 | Posttransplant Medical Adherence: What Have We Learned and Can We Do Better? |
| Q34353156 | Predictive patterns of early medication adherence in renal transplantation |
| Q39959620 | Preferential adherence to immunosuppressive over nonimmunosuppressive medications in kidney transplant recipients |
| Q34807559 | Pretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation |
| Q34448814 | Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study |
| Q49796222 | Prevalence and correlates of non-adherence to immunosuppressants and to health behaviours in patients after kidney transplantation in Brazil - the ADHERE BRAZIL multicentre study: a cross-sectional study protocol. |
| Q34078925 | Prevalence and determinants of physical activity and fluid intake in kidney transplant recipients |
| Q53170445 | Psychological factors associated with medication adherence following renal transplantation. |
| Q36793915 | Psychosocial Predictors of Mortality Following Lung Transplantation |
| Q43151171 | Psychosocial Status of Liver Transplant Candidates in Iran and Its Correlation with Health-Related Quality of Life and Depression and Anxiety |
| Q55271879 | Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation. |
| Q38757443 | Psychosocial predictors of medication adherence in pediatric heart and lung organ transplantation. |
| Q42761144 | Quantifying the impact of nonadherence patterns on exposure to oral immunosuppressants |
| Q60805894 | Quantifying the medication burden of kidney transplant recipients in the first year post-transplantation |
| Q36634442 | Quantitative patterns of azathioprine adherence after renal transplantation |
| Q55401541 | Rejection Prophylaxis in Corneal Transplant. |
| Q38243011 | Renal transplantation in elderly patients. How to select the candidates to the waiting list? |
| Q37323392 | Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients |
| Q33941652 | Safety and efficacy of conversion from twice-daily tacrolimus to once-daily tacrolimus one month after transplantation: randomized controlled trial in adult renal transplantation |
| Q43037516 | Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients. |
| Q36558096 | Selective retransplant after graft loss to nonadherence: success with a second chance. |
| Q35878480 | Self-reported non-adherence and beliefs about medication in a Swedish kidney transplant population |
| Q44583771 | Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors |
| Q47161256 | Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus |
| Q43941042 | Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment. |
| Q37097834 | Standardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation |
| Q40237893 | Steroid- and calcineurin inhibitor free immunosuppression in kidney transplantation: state of the art and future developments. |
| Q40231097 | Stress, coping and adherence to immunosuppressive medications in kidney transplantation: a comparative study. |
| Q53038730 | Stressors and coping resources of Australian kidney transplant recipients related to medication taking: a qualitative study. |
| Q57792530 | Switch from Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Advagraf) in Kidney Transplantation |
| Q33694700 | Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft Rejection |
| Q28087131 | Tacrolimus in preventing transplant rejection in Chinese patients--optimizing use |
| Q36920641 | Tacrolimus once-daily formulation: in the prophylaxis of transplant rejection in renal or liver allograft recipients |
| Q38329297 | Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients |
| Q43061696 | Tacrolimus prolonged release in kidney transplantation |
| Q84211547 | Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen |
| Q41355218 | Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation |
| Q53550268 | Telemedically Supported Case Management of Living-Donor Renal Transplant Recipients to Optimize Routine Evidence-Based Aftercare: A Single-Center Randomized Controlled Trial. |
| Q37604599 | Ten years experience with belatacept-based immunosuppression after kidney transplantation |
| Q39138907 | The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation |
| Q97635158 | The care of kidney transplant recipients during a global pandemic: Challenges and strategies for success |
| Q42690371 | The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial |
| Q38370826 | The need for minimization strategies: current problems of immunosuppression. |
| Q37546101 | The psychological management of facial transplantation. |
| Q38174023 | Tolerance--is it worth it? |
| Q34732869 | Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants |
| Q81548937 | Treatment adherence in renal transplant recipients: a questionnaire survey on immunosuppressants |
| Q89004624 | Unintentional and intentional non-adherence to immunosuppressive medications in renal transplant recipients |
| Q34111508 | Variation in structure and delivery of care between kidney transplant centers in the United States |
| Q59216355 | What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs |
| Q34761349 | What's new in clinical solid organ transplantation by 2013. |
| Q36907097 | Why do Patients Forget to Take Immunosuppression Medications and Miss Appointments: Can a Mobile Phone App Help? |
| Q51787998 | Working together as a team: adolescent transplant recipients and nurse practitioners. |
Search more.